‘Metal-Organic Frameworks’ a Solution to Non-Refrigerated Vaccines: CSIRO

‘Metal-Organic Frameworks’ a Solution to Non-Refrigerated Vaccines: CSIRO
Covid-19 vaccine maker AstraZeneca has revealed it made four billion dollars in sales from its coronavirus jab last year PA
|Updated:

A CSIRO study has found MOFs (metal organic frameworks) to be a possible solution to address the challenge of transporting temperature-dependent vaccines.

According to the study, for vaccines to work with the maximum potency, they must be stored in specific conditions to avoid degradation across manufacturing, distribution, storage as well as administration; also known as the cold chain logistics.
Marina Zhang
Marina Zhang
Author
Marina Zhang is a health reporter for The Epoch Times, based in New York. She covers both health news and in-depth features on emerging health issues. Marina holds a bachelor's degree in biomedicine from the University of Melbourne. Contact her at [email protected].
Related Topics